Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI)

Diabetes and Metabolism

Volumn 37, Issue 5, 2011, Pages 426-431

  Bruttomesso, D ^a,j   Bonomo, M ^b   Costa, S ^a   Dal Pos, M ^a   Di Cianni, G ^c   Pellicano, F ^d   Vitacolonna, E ^e   Dodesini, A R ^f   Tonutti, L ^g   Lapolla, A ^a   Di Benedetto, A ^h   Torlone, E ⁱ  

^a UNIVERSITY OF PADOVA   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d Ravenna Hospital   (Italy)

^e UNIVERSITY OF CHIETI   (Italy)

^f OSPEDALI RIUNITI   (Italy)

^g UNIVERSITY HOSPITAL OF UDINE   (Italy)

^h UNIVERSITY OF MESSINA   (Italy)

ⁱ UNIVERSITY OF PERUGIA   (Italy)

^j UNIVERSITY HOSPITAL OF PADOVA   (Italy)

more..

Author keywords

Continuous subcutaneous insulin infusion; Glargine; Multiple daily injections; Pregnancy; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; METHYLDOPA;

ADULT; ARTICLE; BODY MASS; CHOLESTASIS; CONTINUOUS INFUSION; DIABETES CONTROL; DIABETIC KETOACIDOSIS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE CLASSIFICATION; DISEASE DURATION; DRUG DOSE REGIMEN; FEMALE; FETUS MALFORMATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; METABOLIC REGULATION; MULTICENTER STUDY; PERINATAL MORBIDITY; PERINATAL MORTALITY; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANT WOMAN; RETROSPECTIVE STUDY; TREATMENT OUTCOME; WEIGHT GAIN;

ADULT; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; FEMALE; FETAL DISEASES; HUMANS; HYPOGLYCEMIC AGENTS; INFANT, NEWBORN; INFUSIONS, SUBCUTANEOUS; INSULIN INFUSION SYSTEMS; INSULIN, LONG-ACTING; MORBIDITY; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 81055157154     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2011.02.002     Document Type: Article

References (31)

1. Colquitt J.L., Green C., Sidhu M.K., Hartwell D., Waugh N. Clinical and costeffectiveness of continuous subcutaneous insulin infusion for diabetes. Health Technol Assess 2004, 8(iii):1-171.
2. Fatourechi M.M., Kudva Y.C., Murad M.H., Elamin M.B., Tabini C.C., Montori V.M. Hypoglycemia with intensive insulin therapy: A systematic review and metaanalyses of randomized trials of continuous subcutaneous insulin infusion vs multiple daily injections. J Clin Endocrinol Metab 2009, 94:729-740.
3. Chen R., Ben-Harousch A., Weissmann-Brenner A., Melamed N., Hod M., Yogev Y. Level of glycemic control and pregnancy outcome in type 1 diabetes: a comparison between multiple daily injections and continuous subcutaneous insulin infusions. Am J Obstet Gynecol 2007, 197:404.e1-404.e5.
4. Devlin J.T., Hothershall L., Wilkis J.L. Use of insulin glargine during pregnancy in a Type 1 diabetic woman. Diabetes Care 2002, 25:1095-1096.
5. Holstein A., Plaschke A., Egberts E.H. Use of insulin glargine during embryogenesis in a pregnant woman with Type 1 diabetes. Diabet Med 2003, 20:779-780.
6. Di Cianni G., Volpe L., Lencioni C., Chatzianagnostou K., Cuccuru I., Ghio A., et al. Use of insulin glargine during the first week of pregnancy in five Type 1 diabetic women. Diabetes Care 2005, 28:982-983.
7. Dolci M., Mori M., Baccetti F. Use of glargine before and during pregnancy in a woman with Type 1 diabetes and Addison's disease. Diabetes Care 2005, 28:2084-2085.
8. Woolderink J.M., van Loon A.J., Storms F., de Heide L., Hoogenberg K. Use of insulin glargine during pregnancy in seven Type 1 diabetic women. Diabetes Care 2005, 28:2594-2595.
9. Torlone E., Gennarini A., Ricci N.B., Bolli G.B. Successful use of insulin glargine during entire pregnancy until delivery in six Type 1 diabetic women. Eur J Obstet Gyneco 2007, 132:238-239.
10. Price N., Bartelett C., Gilmer M.D. Use of insulin glargine during pregnancy: a case-control pilot study. Br J Obstet Gynaecol 2007, 11:453-457.
11. Föyhönen-Alho M., Tapani R., Saltevo J., Ekbald U., Kaaja R.J. Use of insulin glargine during pregnancy. Acta Obstet Gynecol Scand 2007, 86:1171-1174.
12. Gallen I.W., Jaap A., Roland J.M., Chirayath H.H. Survey of glargine use in 115 pregnant women with Type 1 diabetes. Diabet Med 2008, 25:165-169.
13. Negrato C.A., Rafacho A., Negrato G., Teiweira M.F., Araùjo C.A.R., Vieira L., et al. Glargine vs NPH insulin therapy in pregnancies complicated by diabetes: an observational cohort study. Diabetes Res Clin Pract 2010, 89:46-51.
14. Pollex E.K., Feig D.S., Lubetsky A., Yip P.M., Koren G. Insulin Glargine safety in pregnancy. Diabetes Care 2010, 33:29-33.
15. Parazzini F., Cortinovis I., Bortulus R., Fedele L., Recarli A. Weight at birth by gestational age in Italy. Hum Reprod 1995, 10:1852-1863.
16. Langer O., Yogev Y., Most O., Xenakis E.M.J. Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol 2005, 192:989-997.
17. Lechat M.F., Dolk H. Registries of congenital anomalies: EUROCAT. Environ Health Perspect 1993, 101:153-157.
18. Johansen K.S., Hodd M. Quality development in perinatal care- the OBSQID project. Int J Gynaecol Obstet 1999, 64:167-172.
19. Bruttomesso D., Costa S., Baritussio A. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy. Diabetes Metab Res Rev 2009, 25:99-111.
20. Hiéronimus S., Capelli C., Bongain A., Durand-Réville M., Berthier F., Fénichel P. Pregnancy in type 1 diabetes : insulin pump versus intensified conventional therapy. Gynecol Obstet Fertil 2005, 33:389-394.
21. Lapolla A., Dalfrà M.G., Masin M., Bruttomesso D., Piva I., Crepaldi C., et al. Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy. Acta Diabetol 2003, 40:143-149.
22. Gabbe S.G., Holing E., Temple P., Brown Z.A. Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus. Am J Obstet Gynecol 2000, 182:1283-1291.
23. Mukhopadhyay A., Farrel T., Fraser R., Ola B. Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials. Am J Obstet Gynecol 2007, 197:447-456.
24. Vanhaverbeke G., Mertens A., Mathieu C. Diabetic management in high risk patients (pregnancy, insulin pumps). Acta Clin Belg 2004, 59:173-181.
25. Rahman W., Rahman F.Z., Yassin S., Al-Suleiman S.A., Rahman J. Clinic Exper Ophtalm 2007, 35:231-236.
26. Nielsen L.R., Damm P., Mathiesen E.R. Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy. Diabetes Care 2009, 32:38-44.
27. Melamed N., Chen R., Soiberman U., Ben-Haroush A., Hod M., Yogev Y. Spontaneous and indicated preterm delivery in pregestational diabetes mellitus: etiology and risk factors. Arch Gynecol Obstet 2008, 278:129-134.
28. Lapolla A., Dalfrà M.G., Di Cianni G., Bonomo M., Parretti E., Mello G. For the Scientific Committee of the GISOGD Group. A multicenter Italian study on pregnancy outcome in women with diabetes. Nutr Metab Cardiovasc Dis 2008, 18:291-297.
29. Suhonen L., Hiilesmaa V., Termo K. Glycaemic control during early pregnancy and fetal malformations in women with type 1 diabetes mellitus. Diabetologia 2000, 43:79-82.
30. Mathiesen E.R., Vaz J.A. Insulin treatment in diabetic pregnancy. Diabetes Metab Res Rev 2008, 24(Suppl 2):S3-S20.
31. Gallen I.W., Jaap A., Roland J.M., Chirayath H.H. Survey of glargine use in 115 pregnant women with Type 1 diabetes. Diabetic Med 2008, 25:165-169.